PMID- 30827909
OWN - NLM
STAT- MEDLINE
DCOM- 20200417
LR  - 20221207
IS  - 2530-0180 (Electronic)
IS  - 2530-0180 (Linking)
VI  - 66
IP  - 7
DP  - 2019 Aug-Sep
TI  - Document on a comprehensive approach to type 2 diabetes mellitus.
PG  - 443-458
LID - S2530-0164(19)30022-9 [pii]
LID - 10.1016/j.endinu.2018.10.010 [doi]
AB  - OBJECTIVE: Treatment of type 2 diabetes mellitus (T2DM) is complex and is 
      intended to decrease morbidity and mortality. Management should therefore include 
      adequate diabetes education, lifestyle changes, drug treatment to achieve early 
      blood glucose control and reduction of cardiovascular (CV) risk factors, early 
      detection and treatment of complications, and assessment of associated 
      comorbidities. The objective was to prepare a document including all aspects 
      required for a comprehensive approach to T2DM. PARTICIPANTS: Members of the 
      Diabetes Mellitus Working Group of the Spanish Society of Endocrinology. METHODS: 
      The available evidence regarding each aspect of diabetes management (blood 
      glucose control goals, diet and exercise, drug treatment, risk factor management 
      and control, detection of complications, and management of frail patients) was 
      reviewed. Recommendations were formulated based on the grades of evidence stated 
      in the 2018 Standards of Medical Care in Diabetes. Recommendations were discussed 
      and agreed by the working group members. CONCLUSIONS: This document is intended 
      to provide evidence-based practical recommendations for comprehensive management 
      of T2DM by clinical endocrinologists.
CI  - Copyright (c) 2019 SEEN y SED. Publicado por Elsevier Espana, S.L.U. All rights 
      reserved.
FAU - Reyes-Garcia, Rebeca
AU  - Reyes-Garcia R
AD  - Unidad de Endocrinologia y Nutricion, Hospital Universitario Torrecardenas, 
      Servicio de Endocrinologia, Clinica San Pedro, Almeria, Espana; Servicio de 
      Endocrinologia, Clinica San Pedro, Almeria, Espana. Electronic address: 
      rebeca.reyes.garcia@gmail.com.
FAU - Moreno-Perez, Oscar
AU  - Moreno-Perez O
AD  - Seccion de Endocrinologia y Nutricion, Hospital General Universitario de 
      Alicante, Universidad Miguel Hernandez, Instituto de Investigacion Sanitaria y 
      Biomedica de Alicante (ISABIAL-FISABIO), Alicante, Espana.
FAU - Tejera-Perez, Cristina
AU  - Tejera-Perez C
AD  - Servicio de Endocrinologia y Nutricion, Complejo Hospitalario Universitario de 
      Ferrol, Ferrol, La Coruna, Espana.
FAU - Fernandez-Garcia, Diego
AU  - Fernandez-Garcia D
AD  - Unidad de Gestion Clinica de Endocrinologia y Nutricion, Hospital Universitario 
      Virgen de la Victoria, Malaga, Espana; Servicio Endocrinologia y Nutricion, 
      Hospital Vithas-Xanit, Benalmadena, Malaga, Espana.
FAU - Bellido-Castaneda, Virginia
AU  - Bellido-Castaneda V
AD  - Servicio de Endocrinologia y Nutricion, Hospital Universitario Cruces, Baracaldo, 
      Vizcaya, Espana.
FAU - de la Torre Casares, Martin Lopez
AU  - de la Torre Casares ML
AD  - Servicio de Endocrinologia y Nutricion, Hospital Universitario Virgen de las 
      Nieves, Granada, Espana.
FAU - Rozas-Moreno, Pedro
AU  - Rozas-Moreno P
AD  - Servicio de Endocrinologia y Nutricion. Hospital General Universitario de Ciudad 
      Real, Ciudad Real, Espana.
FAU - Fernandez-Garcia, Jose Carlos
AU  - Fernandez-Garcia JC
AD  - Unidad de Gestion Clinica de Endocrinologia y Nutricion, Instituto de 
      Investigacion Biomedica de Malaga (IBIMA), Hospital Universitario Virgen de la 
      Victoria, Malaga, Espana; CIBER Fisiopatologia de la Obesidad y Nutricion 
      (CIBERobn), CB06/03, Instituto de Salud Carlos III, Madrid, Espana.
FAU - Marco Martinez, Amparo
AU  - Marco Martinez A
AD  - Endocrinologia y Nutricion, Complejo Hospitalario de Toledo, Toledo, Espana; 
      Hospital Quiron Salud Madrid, Madrid, Espana.
FAU - Escalada-San Martin, Javier
AU  - Escalada-San Martin J
AD  - Departamento de Endocrinologia y Nutricion, Clinica Universidad de Navarra; CIBER 
      Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos 
      III, Madrid, Espana; Grupo de Diabetes y Enfermedades Metabolicas, Instituto de 
      Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Espana.
FAU - Gargallo-Fernandez, Manuel
AU  - Gargallo-Fernandez M
AD  - Seccion de Endocrinologia y Nutricion, Hospital Universitario Infanta Leonor, 
      Madrid, Espana.
FAU - Botana-Lopez, Manuel
AU  - Botana-Lopez M
AD  - Seccion de Endocrinologia y Nutricion, Hospital Universitario Lucus Augusti, 
      Lugo, Espana.
FAU - Lopez-Fernandez, Judith
AU  - Lopez-Fernandez J
AD  - Servicio de Endocrinologia y Nutricion, Hospital Universitario de Canarias, 
      Departamento de Medicina, Universidad de La Laguna, Santa Cruz de Tenerife, 
      Espana.
FAU - Gonzalez-Clemente, Jose Miguel
AU  - Gonzalez-Clemente JM
AD  - Servicio de Endocrinologia y Nutricion, Hospital Parc Tauli, Instituto I3PT-UAB, 
      DIAMET, CIBERDEM-ISCIII, Sabadell, Barcelona, Espana.
FAU - Jodar-Gimeno, Esteban
AU  - Jodar-Gimeno E
AD  - Hospitales Universitarios Quiron Salud, Ruber Juan Bravo y San Jose, Facultad de 
      Ciencias de la Salud, Universidad Europea de Madrid, Madrid, Espana.
FAU - Mezquita-Raya, Pedro
AU  - Mezquita-Raya P
AD  - Unidad de Endocrinologia y Nutricion, Hospital Universitario Torrecardenas, 
      Servicio de Endocrinologia, Clinica San Pedro, Almeria, Espana.
CN  - en representacion del Grupo de trabajo de Diabetes-SEEN
LA  - eng
LA  - spa
PT  - Journal Article
PT  - Practice Guideline
TT  - Documento de abordaje integral de la diabetes tipo 2.
DEP - 20190228
PL  - Spain
TA  - Endocrinol Diabetes Nutr (Engl Ed)
JT  - Endocrinologia, diabetes y nutricion
JID - 101717565
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Insulin)
SB  - IM
MH  - Algorithms
MH  - Cardiovascular Diseases/epidemiology/etiology/prevention & control
MH  - Clinical Trials as Topic
MH  - Combined Modality Therapy
MH  - Comorbidity
MH  - Cost-Benefit Analysis
MH  - Diabetes Complications/prevention & control
MH  - Diabetes Mellitus, Type 2/*therapy
MH  - Diet, Diabetic
MH  - Disease Management
MH  - Dyslipidemias/epidemiology/therapy
MH  - Evidence-Based Medicine
MH  - Exercise
MH  - Glycated Hemoglobin/analysis
MH  - Humans
MH  - Hypertension/epidemiology/therapy
MH  - Hypoglycemic Agents/economics/therapeutic use
MH  - Insulin/administration & dosage/therapeutic use
MH  - Life Style
MH  - Non-alcoholic Fatty Liver Disease/diagnosis/epidemiology
MH  - Patient Education as Topic
MH  - Sleep Apnea Syndromes/epidemiology
OTO - NOTNLM
OT  - Abordaje integral
OT  - Comprehensive management
OT  - Diabetes tipo 2
OT  - Drug treatment
OT  - Lifestyle changes
OT  - Modificaciones de estilo de vida
OT  - Tratamiento farmacologico
OT  - Type 2 diabetes mellitus
EDAT- 2019/03/05 06:00
MHDA- 2020/04/18 06:00
CRDT- 2019/03/05 06:00
PHST- 2018/07/18 00:00 [received]
PHST- 2018/10/21 00:00 [revised]
PHST- 2018/10/31 00:00 [accepted]
PHST- 2019/03/05 06:00 [pubmed]
PHST- 2020/04/18 06:00 [medline]
PHST- 2019/03/05 06:00 [entrez]
AID - S2530-0164(19)30022-9 [pii]
AID - 10.1016/j.endinu.2018.10.010 [doi]
PST - ppublish
SO  - Endocrinol Diabetes Nutr (Engl Ed). 2019 Aug-Sep;66(7):443-458. doi: 
      10.1016/j.endinu.2018.10.010. Epub 2019 Feb 28.